Cell Grafting for Spinal Cord Injury Repair

Cell Replacement and Bridging Strategies

Damien D Pearse, D. J. Barakat

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Recent progress in the development of novel treatments for neurological injury and disease in experimental models has made the clinical success of therapies for spinal cord injury (SCI) repair seem plausible. Transplantation of a heterogeneous population of peripheral and central nervous system, epithelial, immune, and undifferentiated stem or restricted precursor cells has been effective in SCI repair. Cell grafts from these disparate sources have been shown to reduce progressive tissue loss, retard axonal dieback, promote sensory, proprio-, and/or supraspinal axon regeneration, facilitate myelination, and improve functional outcome in experimental models of SCI. Cellular therapies for SCI repair can be classified into three broad categories: cells endogenous to the organism that can be modified or recruited in vivo; cells endogenous to the organism that can be harvested, purified, and/or altered ex vivo and can subsequently be autologously implanted; and cells that can be harvested from one organism, purified and/or modified ex vivo, and transplanted into the injured organism as in allograft or xenograft.

Original languageEnglish
Title of host publicationCellular Transplantation
PublisherElsevier Inc.
Pages477-521
Number of pages45
ISBN (Print)9780123694157
DOIs
StatePublished - Dec 1 2007

Fingerprint

Spinal Cord Regeneration
Spinal Cord Injuries
Repair
Theoretical Models
Neurology
Heterografts
Grafts
Allografts
Peripheral Nervous System
Axons
Tissue
Regeneration
Central Nervous System
Transplantation
Transplants
Wounds and Injuries
Therapeutics
Population

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Cell Grafting for Spinal Cord Injury Repair : Cell Replacement and Bridging Strategies. / Pearse, Damien D; Barakat, D. J.

Cellular Transplantation. Elsevier Inc., 2007. p. 477-521.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pearse, Damien D ; Barakat, D. J. / Cell Grafting for Spinal Cord Injury Repair : Cell Replacement and Bridging Strategies. Cellular Transplantation. Elsevier Inc., 2007. pp. 477-521
@inbook{323c1a87b24c4ae380e5638b3fb8dc3e,
title = "Cell Grafting for Spinal Cord Injury Repair: Cell Replacement and Bridging Strategies",
abstract = "Recent progress in the development of novel treatments for neurological injury and disease in experimental models has made the clinical success of therapies for spinal cord injury (SCI) repair seem plausible. Transplantation of a heterogeneous population of peripheral and central nervous system, epithelial, immune, and undifferentiated stem or restricted precursor cells has been effective in SCI repair. Cell grafts from these disparate sources have been shown to reduce progressive tissue loss, retard axonal dieback, promote sensory, proprio-, and/or supraspinal axon regeneration, facilitate myelination, and improve functional outcome in experimental models of SCI. Cellular therapies for SCI repair can be classified into three broad categories: cells endogenous to the organism that can be modified or recruited in vivo; cells endogenous to the organism that can be harvested, purified, and/or altered ex vivo and can subsequently be autologously implanted; and cells that can be harvested from one organism, purified and/or modified ex vivo, and transplanted into the injured organism as in allograft or xenograft.",
author = "Pearse, {Damien D} and Barakat, {D. J.}",
year = "2007",
month = "12",
day = "1",
doi = "10.1016/B978-012369415-7/50028-4",
language = "English",
isbn = "9780123694157",
pages = "477--521",
booktitle = "Cellular Transplantation",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Cell Grafting for Spinal Cord Injury Repair

T2 - Cell Replacement and Bridging Strategies

AU - Pearse, Damien D

AU - Barakat, D. J.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Recent progress in the development of novel treatments for neurological injury and disease in experimental models has made the clinical success of therapies for spinal cord injury (SCI) repair seem plausible. Transplantation of a heterogeneous population of peripheral and central nervous system, epithelial, immune, and undifferentiated stem or restricted precursor cells has been effective in SCI repair. Cell grafts from these disparate sources have been shown to reduce progressive tissue loss, retard axonal dieback, promote sensory, proprio-, and/or supraspinal axon regeneration, facilitate myelination, and improve functional outcome in experimental models of SCI. Cellular therapies for SCI repair can be classified into three broad categories: cells endogenous to the organism that can be modified or recruited in vivo; cells endogenous to the organism that can be harvested, purified, and/or altered ex vivo and can subsequently be autologously implanted; and cells that can be harvested from one organism, purified and/or modified ex vivo, and transplanted into the injured organism as in allograft or xenograft.

AB - Recent progress in the development of novel treatments for neurological injury and disease in experimental models has made the clinical success of therapies for spinal cord injury (SCI) repair seem plausible. Transplantation of a heterogeneous population of peripheral and central nervous system, epithelial, immune, and undifferentiated stem or restricted precursor cells has been effective in SCI repair. Cell grafts from these disparate sources have been shown to reduce progressive tissue loss, retard axonal dieback, promote sensory, proprio-, and/or supraspinal axon regeneration, facilitate myelination, and improve functional outcome in experimental models of SCI. Cellular therapies for SCI repair can be classified into three broad categories: cells endogenous to the organism that can be modified or recruited in vivo; cells endogenous to the organism that can be harvested, purified, and/or altered ex vivo and can subsequently be autologously implanted; and cells that can be harvested from one organism, purified and/or modified ex vivo, and transplanted into the injured organism as in allograft or xenograft.

UR - http://www.scopus.com/inward/record.url?scp=84882561687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882561687&partnerID=8YFLogxK

U2 - 10.1016/B978-012369415-7/50028-4

DO - 10.1016/B978-012369415-7/50028-4

M3 - Chapter

SN - 9780123694157

SP - 477

EP - 521

BT - Cellular Transplantation

PB - Elsevier Inc.

ER -